Indium-111-labeled autologous leukocyte scanning in gastrointestinal graft versus host disease (GVHD).
The technique of scanning with indium-111 autologous leukocytes has been used to assess gastrointestinal graft-versus-host disease (GVHD) following allogenic marrow transplantation. In patients with active disease, abdominal scans showed extensive abnormal localization in the bowel, while in those whose disease was quiescent after responding to treatment, scans showed localized ileocecal involvement. Rectal histology showed excellent agreement with scanning in the diagnosis of GVHD, but in three of six cases with active disease underestimated disease severity. Indium-111 leukocyte scanning is a useful noninvasive technique for the diagnosis and assessment of gut GVHD.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D005260:Female; D005767:Gastrointestinal Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000209:etiology; D006086:Graft vs Host Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D007204:Indium; D007962:Leukocytes; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000031:analogs & derivatives; D011868:Radioisotopes; D011877:Radionuclide Imaging
D009942:Organometallic Compounds; D011868:Radioisotopes; D007204:Indium; C032950:indium oxine; D015125:Oxyquinoline; D008775:Methylprednisolone